Hyo S. Shim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications
Prognostic Significance of Spread Through Airspaces (STAS) in Stage Ia/bN0 Non-small Cell Lung Cancer - An Evaluation in the JCOG0802/WJOG4607L Clinical Trial Patients.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 11, 2026
Batch Effects in Tumor-Only Next-Generation Sequencing Panel Sequencing and Implications for Copy Number Variant Detection.
Journal: The Journal of molecular diagnostics : JMD
Published: January 07, 2026
Deficiency of GCN5 exacerbates pulmonary fibrosis by disrupting the LKB1-AMPK pathway.
Journal: Cell communication and signaling : CCS
Published: September 03, 2025
Metabolic Tumor Volume as a Predictor of Benefit From Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 03, 2025
Sarcopenia Predicts Outcome After Chemoimmunotherapy, Not Chemotherapy, in Advanced Lung Cancer: Single-Centre Retrospective Study.
Journal: Journal of cachexia, sarcopenia and muscle
Published: August 04, 2025
Characterization of pleural metastasis in non-small cell carcinomas undergoing intraoperative frozen section examination.
Journal: Journal of thoracic disease
Published: July 28, 2025
Genomic classification of intrapulmonary metastasis and multiple primary lung cancer.
Journal: Clinical and translational medicine
Published: June 10, 2025
Definitive radiotherapy for adenoid cystic carcinoma of main bronchus: a case report with 10-year follow-up.
Journal: Frontiers in oncology
Published: April 09, 2025
What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?
What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?
Journal: JTO clinical and research reports
Published: January 01, 2025
Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 20, 2024
Single-cell multi-omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK-positive lung cancer.
Journal: Cancer communications (London, England)
Published: September 26, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy.
Journal: Nature communications
Published: September 25, 2024
Last Updated: 09/26/2026